Dapagliflozin is classified as sodium-glucose co-transporter 2 (SGLT2) inhibitors. They are anti-diabetic medications used to control type 2 diabetes mellitus. They are also used in the treatment of chronic heart failure and chronic kidney disease.
| Weight | 1 kg |
|---|---|
| Dimensions | 25 × 20 × 20 cm |